Related Experiment Video

Updated: Jul 8, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Clinical impact of molecular analysis on thyroid cancer management

Volkert B Wreesmann1, Bhuvanesh Singh

  • 1Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Surgical Oncology Clinics of North America
|January 8, 2008
PubMed

Insights

Molecular alterations in thyroid cancer vary widely, impacting diagnosis, staging, and treatment. Further research into these changes will improve understanding and clinical management of this progressive disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Thyroid cancer presents a spectrum from indolent to fatal forms.
  • Current clinicopathological factors poorly predict thyroid cancer's clinical behavior.
  • Limited therapeutic options exist for aggressive thyroid cancers.

Purpose of the Study:

  • To explore the clinical implications of molecular alterations in thyroid cancer.
  • To enhance diagnostic evaluation, staging, and targeted treatment strategies.
  • To deepen the understanding of thyroid cancer's biologic behavior.

Main Methods:

  • Analysis of molecular alterations in thyroid cancer tissues.
  • Correlation of molecular findings with clinical behavior and outcomes.
  • Review of recent scientific literature on thyroid cancer genomics.

Main Results:

  • Identified a range of molecular alterations across different thyroid cancer subtypes.
  • Demonstrated the utility of molecular markers in diagnosis and staging.
  • Highlighted potential for targeted therapies based on specific molecular profiles.

Conclusions:

  • Molecular analysis is crucial for understanding thyroid cancer progression.
  • Molecular alterations offer promising avenues for improved diagnostic and therapeutic strategies.
  • Continued research in thyroid cancer molecular biology will significantly impact clinical management.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...